Franklin Resources’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-107
Closed -$14.4K 2399
2022
Q4
$14.4K Hold
107
﹤0.01% 2290
2022
Q3
$21K Hold
107
﹤0.01% 2254
2022
Q2
$37K Sell
107
-51
-32% -$21.4K ﹤0.01% 2274
2022
Q1
$93K Hold
158
﹤0.01% 2308
2021
Q4
$145K Sell
158
-1,977
-93% -$2.12M ﹤0.01% 2290
2021
Q3
$2.67M Buy
2,135
+23
+1% +$44.6K ﹤0.01% 1380
2021
Q2
$6.67M Buy
2,112
+235
+13% +$930K ﹤0.01% 1077
2021
Q1
$11.6M Hold
1,877
﹤0.01% 947
2020
Q4
$10.7M Hold
1,877
﹤0.01% 949
2020
Q3
$11.2M Hold
1,877
0.01% 883
2020
Q2
$11.7M Buy
+1,877
New +$12.7M 0.01% 838
2018
Q2
Sell
-56
Closed -$7.52M 1543
2018
Q1
$7.52M Buy
+56
New +$6.81M ﹤0.01% 977

Other funds holding YARW

Franklin Resources's YARW Position: Q1 2023 in Review

Franklin Resources sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2023, closing a stake of 107 shares — an estimated $14.4K sold.

Franklin Resources first reported a position in YARW in Q1 2018 and held it in 12 quarters. The position peaked at $11.7M in Q2 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

  • Franklin Resources reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Franklin Resources sold 107 Yarrow Bioscience, Inc. Common Stock shares in Q1 2023, an estimated $14.4K.
  • Franklin Resources first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and held it in 12 quarters.
  • Franklin Resources's Yarrow Bioscience, Inc. Common Stock position peaked at $11.7M in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.